Daiwa Securities Group Inc. Kodiak Sciences Inc. Transaction History

Daiwa Securities Group Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$80.85 - $128.49 $2,021 - $3,212	-25 Reduced 14.2%	151 $13,000
Q3 2021 Nov 05, 2021	BUY	$81.97 - $106.94 $6,229 - $8,127	76 Added 76.0%	176 $17,000
Q1 2021 May 03, 2021	BUY	$110.45 - $164.47 $552 - $822	5 Added 5.26%	100 $11,000
Q4 2020 Feb 04, 2021	SELL	$60.78 - $154.03 $9,177 - $23,258	-151 Reduced 61.38%	95 $14,000
Q1 2020 May 14, 2020	BUY	$38.18 - $73.95 $1,412 - $2,736	37 Added 17.7%	246 $12,000
Q4 2019 Jan 31, 2020	BUY	$13.9 - $76.65 $2,905 - $16,019	209 New	209 $15,000

109

40.9M

28.4K

21.2K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $190M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

Stay updated on Daiwa Securities Group Inc. with notifications on news.